<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00874003</url>
  </required_header>
  <id_info>
    <org_study_id>GOTABU-BO1</org_study_id>
    <nct_id>NCT00874003</nct_id>
  </id_info>
  <brief_title>The Effects of Mirtazapine Versus Placebo on Alcohol Consumption in Male Alcohol High Consumers</brief_title>
  <official_title>The Effects of Mirtazapine vs Placebo on Alcohol Consumption in Male Alcohol High Consumers; a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effects of 8 weeks of treatment with mirtazapine on
      alcohol consumption in alcohol high consuming men. This study is a randomized, double-blind
      placebo controlled clinical trial with parallel group design(N=59).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">July 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alcohol consumption measured by alcohol diary (units/week).</measure>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Alcohol Dependence</condition>
  <arm_group>
    <arm_group_label>mirtazapine, tablet, 30 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>n=29</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>n=30</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>mirtazapine</intervention_name>
    <description>oral tablet, 30 mg daily</description>
    <arm_group_label>mirtazapine, tablet, 30 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>oral tablet, 1 daily</description>
    <arm_group_label>sugar pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 years of age

          -  male sex

          -  alcohol high consumption

          -  signed informed consent

        Exclusion Criteria:

          -  psychiatric disorders (except nicotine and alcohol dependence)

          -  severe somatic disorders

          -  inadequate knowledge of the Swedish language
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea deBejczy, MD</last_name>
    <role>Study Director</role>
    <affiliation>Addiction Biology Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bo Söderpalm, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Addiction Biology Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Addiction Biology Unit</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2009</study_first_submitted>
  <study_first_submitted_qc>April 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2009</study_first_posted>
  <last_update_submitted>April 1, 2009</last_update_submitted>
  <last_update_submitted_qc>April 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Bo Söderpalm/ MD, PhD, sponsor</name_title>
    <organization>Addiction Biology Unit, Sahlgrenska University Hospital, Sweden</organization>
  </responsible_party>
  <keyword>alcohol dependence</keyword>
  <keyword>anti-depressant</keyword>
  <keyword>5-HT</keyword>
  <keyword>NE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Mirtazapine</mesh_term>
    <mesh_term>Mianserin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

